Amarin Corporation

9.43
0.13 (1.40%)
At close: Apr 14, 2025, 3:47 PM
1.40%
Bid 9.38
Market Cap 195.19M
Revenue (ttm) 228.66M
Net Income (ttm) -82.18M
EPS (ttm) -4
PE Ratio (ttm) -2.36
Forward PE -2.69
Analyst n/a
Ask 9.47
Volume 181,351
Avg. Volume (20D) 79,253
Open 9.22
Previous Close 9.30
Day's Range 8.32 - 9.48
52-Week Range 7.00 - 20.60
Beta 1.39

About AMRN

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its p...

Industry Biotechnology
Sector Healthcare
IPO Date Apr 1, 1993
Employees 275
Stock Exchange NASDAQ
Ticker Symbol AMRN
Full Company Profile

Next Earnings Release

Amarin Corporation is scheduled to release its earnings on Apr 30, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-14.98%
Amarin Corporation shares are trading lower after ... Unlock content with Pro Subscription
8 months ago
-12.84%
Amarin shares are trading lower. The company reported Q2 financial results.